Smartleaf Asset Management’s Tango Therapeutics TNGX Stock Holding History

Smartleaf Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.91K	Buy	+119	New	+$3.1K	﹤0.01%	2921

Other funds holding TNGX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Smartleaf Asset Management's TNGX Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Tango Therapeutics (TNGX) in Q3 2026: 119 shares worth $2.91K. The stake represents ﹤0.01% of the portfolio and ranks #2921 among its holdings.

161 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

Smartleaf Asset Management held 119 shares of Tango Therapeutics worth $2.91K as of Q3 2026.
Tango Therapeutics was a new Smartleaf Asset Management position in Q3 2026.
Tango Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #2921 holding.
161 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.